<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39448844</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-4469</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>24</Day></PubDate></JournalIssue><Title>Nature chemical biology</Title><ISOAbbreviation>Nat Chem Biol</ISOAbbreviation></Journal><ArticleTitle>Delineating cysteine-reactive compound modulation of cellular proteostasis processes.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41589-024-01760-9</ELocationID><Abstract><AbstractText>Covalent modulators and covalent degrader molecules have emerged as drug modalities with tremendous therapeutic potential. Toward realizing this potential, mass spectrometry-based chemoproteomic screens have generated proteome-wide maps of potential druggable cysteine residues. However, beyond these direct cysteine-target maps, the full scope of direct and indirect activities of these molecules on cellular processes and how such activities contribute to reported modes of action, such as degrader activity, remains to be fully understood. Using chemoproteomics, we identified a cysteine-reactive small molecule degrader of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nonstructural protein 14 (nsp14), which effects degradation through direct modification of cysteines in both nsp14 and in host protein disulfide isomerases. This degrader activity was further potentiated by generalized electrophile-induced global protein ubiquitylation, proteasome activation and widespread aggregation and depletion of host proteins, including the formation of stress granules. Collectively, we delineate the wide-ranging impacts of cysteine-reactive electrophilic compounds on cellular proteostasis processes.</AbstractText><CopyrightInformation>© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Julio</LastName><ForeName>Ashley R</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0002-6258-2849</Identifier><AffiliationInfo><Affiliation>Department of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Shikwana</LastName><ForeName>Flowreen</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Truong</LastName><ForeName>Cindy</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burton</LastName><ForeName>Nikolas R</ForeName><Initials>NR</Initials><Identifier Source="ORCID">0000-0003-2887-8846</Identifier><AffiliationInfo><Affiliation>Department of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dominguez</LastName><ForeName>Emil R</ForeName><Initials>ER</Initials><Suffix>3rd</Suffix><AffiliationInfo><Affiliation>Department of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turmon</LastName><ForeName>Alexandra C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Backus</LastName><ForeName>Keriann M</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0001-8541-1404</Identifier><AffiliationInfo><Affiliation>Department of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. kbackus@mednet.ucla.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, UCLA, Los Angeles, CA, USA. kbackus@mednet.ucla.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DOE Institute for Genomics and Proteomics, UCLA, Los Angeles, CA, USA. kbackus@mednet.ucla.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. kbackus@mednet.ucla.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. kbackus@mednet.ucla.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Beckman Young Investigator Award</GrantID><Agency>Arnold and Mabel Beckman Foundation</Agency><Country /></Grant><Grant><GrantID>D19AP00041</GrantID><Agency>United States Department of Defense | Defense Advanced Research Projects Agency (DARPA)</Agency><Country /></Grant><Grant><GrantID>GM146246-02</GrantID><Agency>U.S. Department of Health &amp; Human Services | National Institutes of Health (NIH)</Agency><Country /></Grant><Grant><GrantID>T32GM136614</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Institute of General Medical Sciences (NIGMS)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Chem Biol</MedlineTA><NlmUniqueID>101231976</NlmUniqueID><ISSNLinking>1552-4450</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>0</Hour><Minute>49</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39448844</ArticleId><ArticleId IdType="doi">10.1038/s41589-024-01760-9</ArticleId><ArticleId IdType="pii">10.1038/s41589-024-01760-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Boatner, L. M., Palafox, M. F., Schweppe, D. K. &amp; Backus, K. M. CysDB: a human cysteine database based on experimental quantitative chemoproteomics. Cell Chem. Biol. 30, 683–698 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37119813</ArticleId><ArticleId IdType="pmc">10510411</ArticleId><ArticleId IdType="doi">10.1016/j.chembiol.2023.04.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Backus, K. M. et al. Proteome-wide covalent ligand discovery in native biological systems. Nature 534, 570–574 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27309814</ArticleId><ArticleId IdType="pmc">4919207</ArticleId><ArticleId IdType="doi">10.1038/nature18002</ArticleId></ArticleIdList></Reference><Reference><Citation>Weerapana, E. et al. Quantitative reactivity profiling predicts functional cysteines in proteomes. Nature 468, 790–795 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">21085121</ArticleId><ArticleId IdType="pmc">3058684</ArticleId><ArticleId IdType="doi">10.1038/nature09472</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao, J. et al. Multiplexed CuAAC Suzuki–Miyaura labeling for tandem activity-based chemoproteomic profiling. Anal. Chem. 93, 2610–2618 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33470097</ArticleId><ArticleId IdType="pmc">8849040</ArticleId><ArticleId IdType="doi">10.1021/acs.analchem.0c04726</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinogradova, E. V. et al. An activity-guided map of electrophile–cysteine interactions in primary human T cells. Cell 182, 1009–1026 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32730809</ArticleId><ArticleId IdType="pmc">7775622</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2020.07.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan, T. et al. SP3-FAIMS chemoproteomics for high-coverage profiling of the human cysteinome. ChemBioChem 22, 1841–1851 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33442901</ArticleId><ArticleId IdType="pmc">8942723</ArticleId><ArticleId IdType="doi">10.1002/cbic.202000870</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuljanin, M. et al. Reimagining high-throughput profiling of reactive cysteines for cell-based screening of large electrophile libraries. Nat. Biotechnol. 39, 630–641 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33398154</ArticleId><ArticleId IdType="pmc">8316984</ArticleId><ArticleId IdType="doi">10.1038/s41587-020-00778-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Burton, N. R. et al. Solid-phase compatible silane-based cleavable linker enables custom isobaric quantitative chemoproteomics. J. Am. Chem. Soc. 145, 21303–21318 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37738129</ArticleId><ArticleId IdType="doi">10.1021/jacs.3c05797</ArticleId></ArticleIdList></Reference><Reference><Citation>Mader, M. M. et al. Which small molecule? Selecting chemical probes for use in cancer research and target validation. Cancer Discov. 13, 2150–2165 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37712569</ArticleId><ArticleId IdType="doi">10.1158/2159-8290.CD-23-0536</ArticleId></ArticleIdList></Reference><Reference><Citation>Antolin, A. A. et al. The Chemical Probes Portal: an expert review-based public resource to empower chemical probe assessment, selection and use. Nucleic Acids Res. 51, D1492–D1502 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36268860</ArticleId><ArticleId IdType="doi">10.1093/nar/gkac909</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartung, I. V., Rudolph, J., Mader, M. M., Mulder, M. P. C. &amp; Workman, P. Expanding chemical probe space: quality criteria for covalent and degrader probes. J. Med. Chem. 66, 9297–9312 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37403870</ArticleId><ArticleId IdType="pmc">10388296</ArticleId><ArticleId IdType="doi">10.1021/acs.jmedchem.3c00550</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavanagh, M. E. et al. Selective inhibitors of JAK1 targeting an isoform-restricted allosteric cysteine. Nat. Chem. Biol. 18, 1388–1398 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36097295</ArticleId><ArticleId IdType="pmc">7614775</ArticleId><ArticleId IdType="doi">10.1038/s41589-022-01098-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrem, J. M., Peters, U., Sos, M. L., Wells, J. A. &amp; Shokat, K. M. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature 503, 548–551 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24256730</ArticleId><ArticleId IdType="pmc">4274051</ArticleId><ArticleId IdType="doi">10.1038/nature12796</ArticleId></ArticleIdList></Reference><Reference><Citation>Janes, M. R. et al. Targeting KRAS mutant cancers with a covalent G12C-specific inhibitor. Cell 172, 578–589.e17 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29373830</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2018.01.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson, P. et al. Physical and functional analysis of the putative rpn13 inhibitor RA190. Cell Chem. Biol. 27, 1371–1382 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32857985</ArticleId><ArticleId IdType="pmc">7680414</ArticleId><ArticleId IdType="doi">10.1016/j.chembiol.2020.08.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Anchoori, R. K. et al. A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer. Cancer Cell 24, 791–805 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24332045</ArticleId><ArticleId IdType="doi">10.1016/j.ccr.2013.11.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamayun, I. et al. Eeyarestatin compounds selectively enhance Sec61-mediated Ca<sup>2+</sup> leakage from the endoplasmic reticulum. Cell Chem. Biol. 26, 571–583 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30799222</ArticleId><ArticleId IdType="pmc">6483976</ArticleId><ArticleId IdType="doi">10.1016/j.chembiol.2019.01.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, K. et al. Stress granule assembly disrupts nucleocytoplasmic transport. Cell 173, 958–971.e17 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29628143</ArticleId><ArticleId IdType="pmc">6083872</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2018.03.025</ArticleId></ArticleIdList></Reference><Reference><Citation>Othumpangat, S., Kashon, M. &amp; Joseph, P. Sodium arsenite-induced inhibition of eukaryotic translation initiation factor 4E (eIF4E) results in cytotoxicity and cell death. Mol. Cell. Biochem. 279, 123–131 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16283521</ArticleId><ArticleId IdType="doi">10.1007/s11010-005-8284-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopito, R. R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10, 524–530 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11121744</ArticleId><ArticleId IdType="doi">10.1016/S0962-8924(00)01852-3</ArticleId></ArticleIdList></Reference><Reference><Citation>García-Mata, R., Bebök, Z., Sorscher, E. J. &amp; Sztul, E. S. Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera. J. Cell Biol. 146, 1239–1254 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10491388</ArticleId><ArticleId IdType="pmc">2156127</ArticleId><ArticleId IdType="doi">10.1083/jcb.146.6.1239</ArticleId></ArticleIdList></Reference><Reference><Citation>Forte, N. et al. Targeted Protein Degradation through E2 Recruitment. ACS Chem. Biol. 18, 897–904 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36940189</ArticleId><ArticleId IdType="pmc">10127205</ArticleId><ArticleId IdType="doi">10.1021/acschembio.3c00040</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, X., Crowley, V. M., Wucherpfennig, T. G., Dix, M. M. &amp; Cravatt, B. F. Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16. Nat. Chem. Biol. 15, 737–746 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31209349</ArticleId><ArticleId IdType="pmc">6592777</ArticleId><ArticleId IdType="doi">10.1038/s41589-019-0279-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao, Y. et al. Targeted protein degradation by electrophilic PROTACs that stereoselectively and site-specifically engage DCAF1. J. Am. Chem. Soc. 144, 18688–18699 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36170674</ArticleId><ArticleId IdType="pmc">10347610</ArticleId><ArticleId IdType="doi">10.1021/jacs.2c08964</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, X. et al. DCAF11 supports targeted protein degradation by electrophilic proteolysis targeting chimeras. J. Am. Chem. Soc. 143, 5141–5149 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33783207</ArticleId><ArticleId IdType="pmc">8309050</ArticleId><ArticleId IdType="doi">10.1021/jacs.1c00990</ArticleId></ArticleIdList></Reference><Reference><Citation>Spradlin, J. N. et al. Harnessing the anti-cancer natural product nimbolide for targeted protein degradation. Nat. Chem. Biol. 15, 747–755 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31209351</ArticleId><ArticleId IdType="pmc">6592714</ArticleId><ArticleId IdType="doi">10.1038/s41589-019-0304-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward, C. C. et al. Covalent ligand screening uncovers a RNF4 E3 ligase recruiter for targeted protein degradation applications. ACS Chem. Biol. 14, 2430–2440 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31059647</ArticleId><ArticleId IdType="pmc">7422721</ArticleId><ArticleId IdType="doi">10.1021/acschembio.8b01083</ArticleId></ArticleIdList></Reference><Reference><Citation>Henning, N. J. et al. Discovery of a covalent FEM1B recruiter for targeted protein degradation applications. J. Am. Chem. Soc. 144, 701–708 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34994556</ArticleId><ArticleId IdType="pmc">8928484</ArticleId><ArticleId IdType="doi">10.1021/jacs.1c03980</ArticleId></ArticleIdList></Reference><Reference><Citation>Isobe, Y. et al. Manumycin polyketides act as molecular glues between UBR7 and P53. Nat. Chem. Biol. 16, 1189–1198 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32572277</ArticleId><ArticleId IdType="pmc">7572527</ArticleId><ArticleId IdType="doi">10.1038/s41589-020-0557-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Toriki, E. S. et al. Rational chemical design of molecular glue degraders. ACS Cent. Sci. 9, 915–926 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37252349</ArticleId><ArticleId IdType="pmc">10214506</ArticleId><ArticleId IdType="doi">10.1021/acscentsci.2c01317</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarott, R. C. et al. Chemical specification of E3 ubiquitin ligase engagement by cysteine-reactive chemistry. J. Am. Chem. Soc. 145, 21937–21944 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37767920</ArticleId><ArticleId IdType="doi">10.1021/jacs.3c06622</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Y.-D. et al. Template-assisted covalent modification underlies activity of covalent molecular glues. Nat. Chem. Biol. https://doi.org/10.1038/s41589-024-01668-4 (2024).</Citation></Reference><Reference><Citation>Hassan, M. M. et al. Exploration of the tunability of BRD4 degradation by DCAF16 trans-labelling covalent glues. Eur. J. Med. Chem. 279, 116904 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">39341093</ArticleId><ArticleId IdType="doi">10.1016/j.ejmech.2024.116904</ArticleId></ArticleIdList></Reference><Reference><Citation>King, E. A. et al. Chemoproteomics-enabled discovery of a covalent molecular glue degrader targeting NF-κB. Cell Chem. Biol. 30, 394–402 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36898369</ArticleId><ArticleId IdType="doi">10.1016/j.chembiol.2023.02.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong, S. H. et al. Exploiting the cullin E3 ligase adaptor protein SKP1 for targeted protein degradation. ACS Chem. Biol. 19, 442–450 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38305738</ArticleId><ArticleId IdType="pmc">10999000</ArticleId><ArticleId IdType="doi">10.1021/acschembio.3c00642</ArticleId></ArticleIdList></Reference><Reference><Citation>Littler, D. R., Gully, B. S., Colson, R. N. &amp; Rossjohn, J. Crystal structure of the SARS-CoV-2 non-structural protein 9, Nsp9. iScience 23, 101258 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32592996</ArticleId><ArticleId IdType="pmc">7282741</ArticleId><ArticleId IdType="doi">10.1016/j.isci.2020.101258</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma, Y. et al. Structural basis and functional analysis of the SARS coronavirus nsp14–nsp10 complex. Proc. Natl Acad. Sci. USA 112, 9436–9441 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26159422</ArticleId><ArticleId IdType="pmc">4522806</ArticleId><ArticleId IdType="doi">10.1073/pnas.1508686112</ArticleId></ArticleIdList></Reference><Reference><Citation>Decroly, E. et al. Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2′-O-methyltransferase nsp10/nsp16 complex. PLoS Pathog. 7, e1002059 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21637813</ArticleId><ArticleId IdType="pmc">3102710</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1002059</ArticleId></ArticleIdList></Reference><Reference><Citation>Imprachim, N., Yosaatmadja, Y. &amp; Newman, J. A. Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal details of exoribonuclease activation and mRNA capping and provide starting points for antiviral drug development. Nucleic Acids Res. 51, 475–487 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36546776</ArticleId><ArticleId IdType="doi">10.1093/nar/gkac1207</ArticleId></ArticleIdList></Reference><Reference><Citation>Liby, K. et al. The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling. Cancer Res. 65, 4789–4798 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15930299</ArticleId><ArticleId IdType="doi">10.1158/0008-5472.CAN-04-4539</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, D. et al. Systematic targeting of protein complexes with molecular COUPLrs. Preprint a bioRxiv https://doi.org/10.1101/2024.07.16.603666 (2024).</Citation></Reference><Reference><Citation>Mauvezin, C. &amp; Neufeld, T. P. Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A/SERCA-dependent autophagosome-lysosome fusion. Autophagy 11, 1437–1438 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26156798</ArticleId><ArticleId IdType="pmc">4590655</ArticleId><ArticleId IdType="doi">10.1080/15548627.2015.1066957</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohtake, F., Tsuchiya, H., Saeki, Y. &amp; Tanaka, K. K63 ubiquitylation triggers proteasomal degradation by seeding branched ubiquitin chains. Proc. Natl Acad. Sci. USA 115, E1401–E1408 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29378950</ArticleId><ArticleId IdType="pmc">5816176</ArticleId><ArticleId IdType="doi">10.1073/pnas.1716673115</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon, D. E. et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583, 459–468 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32353859</ArticleId><ArticleId IdType="pmc">7431030</ArticleId><ArticleId IdType="doi">10.1038/s41586-020-2286-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Grantham, J. The molecular chaperone CCT/TRiC: an essential component of proteostasis and a potential modulator of protein aggregation. Front. Genet. 11, 172 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32265978</ArticleId><ArticleId IdType="pmc">7096549</ArticleId><ArticleId IdType="doi">10.3389/fgene.2020.00172</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashore, C. et al. Targeted degradation via direct 26S proteasome recruitment. Nat. Chem. Biol. 19, 55–63 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36577875</ArticleId><ArticleId IdType="doi">10.1038/s41589-022-01218-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Tofaris, G. K., Layfield, R. &amp; Spillantini, M. G. α-Synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome. FEBS Lett. 509, 22–26 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11734199</ArticleId><ArticleId IdType="doi">10.1016/S0014-5793(01)03115-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, M. et al. HUWE1 amplifies ubiquitin modifications to broadly stimulate clearance of proteins and aggregates. Preprint at bioRxiv https://doi.org/10.1101/2023.05.30.542866 (2023).</Citation></Reference><Reference><Citation>Sarkar, A. A. &amp; Zohn, I. E. Hectd1 regulates intracellular localization and secretion of Hsp90 to control cellular behavior of the cranial mesenchyme. J. Cell Biol. 196, 789–800 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22431752</ArticleId><ArticleId IdType="pmc">3308699</ArticleId><ArticleId IdType="doi">10.1083/jcb.201105101</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Q., Li, L. &amp; Ye, Y. Inhibition of p97-dependent protein degradation by eeyarestatin I. J. Biol. Chem. 283, 7445–7454 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18199748</ArticleId><ArticleId IdType="pmc">2276333</ArticleId><ArticleId IdType="doi">10.1074/jbc.M708347200</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkers, C. R. et al. Profiling proteasome activity in tissue with fluorescent probes. Mol. Pharm. 4, 739–748 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17708652</ArticleId><ArticleId IdType="doi">10.1021/mp0700256</ArticleId></ArticleIdList></Reference><Reference><Citation>Leestemaker, Y. et al. Proteasome activation by small molecules. Cell Chem. Biol. 24, 725–736 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28552582</ArticleId><ArticleId IdType="doi">10.1016/j.chembiol.2017.05.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Vetma, V. et al. Confounding factors in targeted degradation of short-lived proteins. ACS Chem. Biol. 19, 1484–1494 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38958654</ArticleId><ArticleId IdType="doi">10.1021/acschembio.4c00152</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060–1072 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22632970</ArticleId><ArticleId IdType="pmc">3367386</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2012.03.042</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins, L. G. et al. Transcription factor Nrf2 mediates an adaptive response to sulforaphane that protects fibroblasts in vitro against the cytotoxic effects of electrophiles, peroxides and redox-cycling agents. Toxicol. Appl. Pharmacol. 237, 267–280 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19303893</ArticleId><ArticleId IdType="doi">10.1016/j.taap.2009.03.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetz, C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat. Rev. Mol. Cell Biol. 13, 89–102 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22251901</ArticleId><ArticleId IdType="doi">10.1038/nrm3270</ArticleId></ArticleIdList></Reference><Reference><Citation>Edman, J. C., Ellis, L., Blacher, R. W., Roth, R. A. &amp; Rutter, W. J. Sequence of protein disulphide isomerase and implications of its relationship to thioredoxin. Nature 317, 267–270 (1985).</Citation><ArticleIdList><ArticleId IdType="pubmed">3840230</ArticleId><ArticleId IdType="doi">10.1038/317267a0</ArticleId></ArticleIdList></Reference><Reference><Citation>Plate, L. et al. Small molecule proteostasis regulators that reprogram the ER to reduce extracellular protein aggregation. eLife 5, e15550 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27435961</ArticleId><ArticleId IdType="pmc">4954754</ArticleId><ArticleId IdType="doi">10.7554/eLife.15550</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffstrom, B. G. et al. Inhibitors of protein disulfide isomerase suppress apoptosis induced by misfolded proteins. Nat. Chem. Biol. 6, 900–906 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">21079601</ArticleId><ArticleId IdType="pmc">3018711</ArticleId><ArticleId IdType="doi">10.1038/nchembio.467</ArticleId></ArticleIdList></Reference><Reference><Citation>Jean, S., Cox, S., Nassari, S. &amp; Kiger, A. A. Starvation-induced MTMR13 and RAB21 activity regulates VAMP8 to promote autophagosome-lysosome fusion. EMBO Rep. 16, 297–311 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25648148</ArticleId><ArticleId IdType="pmc">4364869</ArticleId><ArticleId IdType="doi">10.15252/embr.201439464</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y. et al. A novel mechanism for NF-κB activation via IκB aggregation: Implications for hepatic Mallory-Denk-body induced inflammation. Mol. Cell. Proteomics 19, 1968–1986 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32912968</ArticleId><ArticleId IdType="pmc">7710137</ArticleId><ArticleId IdType="doi">10.1074/mcp.RA120.002316</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, P. et al. G3BP1 is a tunable switch that triggers phase separation to assemble stress granules. Cell 181, 325–345 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32302571</ArticleId><ArticleId IdType="pmc">7448383</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2020.03.046</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinkova-Kostova, A. T. et al. Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. Proc. Natl Acad. Sci. USA 102, 4584–4589 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15767573</ArticleId><ArticleId IdType="pmc">555528</ArticleId><ArticleId IdType="doi">10.1073/pnas.0500815102</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y. et al. Sulforaphane enhances proteasomal and autophagic activities in mice and is a potential therapeutic reagent for Huntington’s disease. J. Neurochem. 129, 539–547 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24383989</ArticleId><ArticleId IdType="pmc">3997618</ArticleId><ArticleId IdType="doi">10.1111/jnc.12647</ArticleId></ArticleIdList></Reference><Reference><Citation>Gromer, S., Arscott, L. D., Williams, C. H., Schirmer, R. H. &amp; Becker, K. Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds. J. Biol. Chem. 273, 20096–20101 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9685351</ArticleId><ArticleId IdType="doi">10.1074/jbc.273.32.20096</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, J. et al. Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathway. Cell 186, 2361–2379 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37192619</ArticleId><ArticleId IdType="pmc">10225361</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2023.04.026</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao, X. et al. Novel multi-targeted ErbB family inhibitor afatinib blocks EGF-induced signaling and induces apoptosis in neuroblastoma. Oncotarget 8, 1555–1568 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27902463</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.13657</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, F. et al. Repurposing of ibrutinib and quizartinib as potent inhibitors of necroptosis. Commun. Biol. 6, 972 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37741898</ArticleId><ArticleId IdType="pmc">10517925</ArticleId><ArticleId IdType="doi">10.1038/s42003-023-05353-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapoor, I. et al. Resistance to BTK inhibition by ibrutinib can be overcome by preventing FOXO3a nuclear export and PI3K/AKT activation in B-cell lymphoid malignancies. Cell Death Dis. 10, 924 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31801949</ArticleId><ArticleId IdType="pmc">6892912</ArticleId><ArticleId IdType="doi">10.1038/s41419-019-2158-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanning, B. R. et al. A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors. Nat. Chem. Biol. 10, 760–767 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25038787</ArticleId><ArticleId IdType="pmc">4138289</ArticleId><ArticleId IdType="doi">10.1038/nchembio.1582</ArticleId></ArticleIdList></Reference><Reference><Citation>Trendel, J. et al. The human RNA-binding proteome and its dynamics during translational arrest. Cell 176, 391–403 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30528433</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2018.11.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, X. et al. Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships. J. Med. Chem. 54, 809–816 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21241062</ArticleId><ArticleId IdType="pmc">3139710</ArticleId><ArticleId IdType="doi">10.1021/jm101199t</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda, S. et al. Stress- and ubiquitylation-dependent phase separation of the proteasome. Nature 578, 296–300 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32025036</ArticleId><ArticleId IdType="doi">10.1038/s41586-020-1982-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Gwon, Y. et al. Ubiquitination of G3BP1 mediates stress granule disassembly in a context-specific manner. Science 372, eabf6548 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34739333</ArticleId><ArticleId IdType="pmc">8574224</ArticleId><ArticleId IdType="doi">10.1126/science.abf6548</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston, J. A., Ward, C. L. &amp; Kopito, R. R. Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 143, 1883–1898 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9864362</ArticleId><ArticleId IdType="pmc">2175217</ArticleId><ArticleId IdType="doi">10.1083/jcb.143.7.1883</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, C. et al. Autophagic sequestration of SQSTM1 disrupts the aggresome formation of ubiquitinated proteins during proteasome inhibition. Cell Death Dis. 13, 615 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35840557</ArticleId><ArticleId IdType="pmc">9287315</ArticleId><ArticleId IdType="doi">10.1038/s41419-022-05061-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, C. et al. Afatinib combined with anti-PD1 enhances immunotherapy of hepatocellular carcinoma via ERBB2/STAT3/PD-L1 signaling. Front. Oncol. 13, 1198118 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37324014</ArticleId><ArticleId IdType="pmc">10266343</ArticleId><ArticleId IdType="doi">10.3389/fonc.2023.1198118</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, D. et al. BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models. Oncogene 27, 4702–4711 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18408761</ArticleId><ArticleId IdType="pmc">2748240</ArticleId><ArticleId IdType="doi">10.1038/onc.2008.109</ArticleId></ArticleIdList></Reference><Reference><Citation>Bar-Peled, L. et al. Chemical proteomics identifies druggable vulnerabilities in a genetically defined cancer. Cell 171, 696–709 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28965760</ArticleId><ArticleId IdType="pmc">5728659</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2017.08.051</ArticleId></ArticleIdList></Reference><Reference><Citation>Abegg, D. et al. Proteome-wide profiling of targets of cysteine reactive small molecules by using ethynyl benziodoxolone reagents. Angew. Chem. 127, 11002–11007 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ange.201505641</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossman, E. A. et al. Covalent ligand discovery against druggable hotspots targeted by anti-cancer natural products. Cell Chem. Biol. 24, 1368–1376 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28919038</ArticleId><ArticleId IdType="pmc">5693770</ArticleId><ArticleId IdType="doi">10.1016/j.chembiol.2017.08.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, C., Weerapana, E., Blewett, M. M. &amp; Cravatt, B. F. A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles. Nat. Methods 11, 79–85 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24292485</ArticleId><ArticleId IdType="doi">10.1038/nmeth.2759</ArticleId></ArticleIdList></Reference><Reference><Citation>Henning, N. J. et al. Deubiquitinase-targeting chimeras for targeted protein stabilization. Nat. Chem. Biol. 18, 412–421 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35210618</ArticleId><ArticleId IdType="pmc">10125259</ArticleId><ArticleId IdType="doi">10.1038/s41589-022-00971-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazear, M. R. et al. Proteomic discovery of chemical probes that perturb protein complexes in human cells. Mol. Cell 83, 1725–1742 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37084731</ArticleId><ArticleId IdType="doi">10.1016/j.molcel.2023.03.026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kathman, S. G. et al. Remodeling oncogenic transcriptomes by small molecules targeting NONO. Nat. Chem. Biol. 19, 825–836 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36864190</ArticleId><ArticleId IdType="pmc">10337234</ArticleId><ArticleId IdType="doi">10.1038/s41589-023-01270-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterling, J., Baker, J. R., McCluskey, A. &amp; Munoz, L. Systematic literature review reveals suboptimal use of chemical probes in cell-based biomedical research. Nat. Commun. 14, 3228 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37270653</ArticleId><ArticleId IdType="pmc">10239480</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-38952-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, H. et al. Assigning functionality to cysteines by base editing of cancer dependency genes. Nat. Chem. Biol. 19, 1320–1330 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37783940</ArticleId><ArticleId IdType="pmc">10698195</ArticleId><ArticleId IdType="doi">10.1038/s41589-023-01428-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, Y. et al. Direct mapping of ligandable tyrosines and lysines in cells with chiral sulfonyl fluoride probes. Nat. Chem. 15, 1616–1625 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37460812</ArticleId><ArticleId IdType="doi">10.1038/s41557-023-01281-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Resnick, E. et al. Rapid covalent-probe discovery by electrophile-fragment screening. J. Am. Chem. Soc. 141, 8951–8968 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31060360</ArticleId><ArticleId IdType="pmc">6556873</ArticleId><ArticleId IdType="doi">10.1021/jacs.9b02822</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubiella, C. et al. Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo. Nat. Chem. Biol. 17, 954–963 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33972797</ArticleId><ArticleId IdType="pmc">9119696</ArticleId><ArticleId IdType="doi">10.1038/s41589-021-00786-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Branon, T. C. et al. Efficient proximity labeling in living cells and organisms with TurboID. Nat. Biotechnol. 36, 880–887 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30125270</ArticleId><ArticleId IdType="pmc">6126969</ArticleId><ArticleId IdType="doi">10.1038/nbt.4201</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, H. &amp; Naismith, J. H. An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol. BMC Biotechnol. 8, 91 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">19055817</ArticleId><ArticleId IdType="pmc">2629768</ArticleId><ArticleId IdType="doi">10.1186/1472-6750-8-91</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider, C. A., Rasband, W. S. &amp; Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22930834</ArticleId><ArticleId IdType="pmc">5554542</ArticleId><ArticleId IdType="doi">10.1038/nmeth.2089</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23586463</ArticleId><ArticleId IdType="pmc">3637064</ArticleId><ArticleId IdType="doi">10.1186/1471-2105-14-128</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, Z. et al. Gene set knowledge discovery with Enrichr. Curr. Protoc. 1, e90 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33780170</ArticleId><ArticleId IdType="pmc">8152575</ArticleId><ArticleId IdType="doi">10.1002/cpz1.90</ArticleId></ArticleIdList></Reference><Reference><Citation>Teo, G. C., Polasky, D. A., Yu, F. &amp; Nesvizhskii, A. I. Fast deisotoping algorithm and its implementation in the msfragger search engine. J. Proteome Res. 20, 498–505 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33332123</ArticleId><ArticleId IdType="doi">10.1021/acs.jproteome.0c00544</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong, A. T., Leprevost, F. V., Avtonomov, D. M., Mellacheruvu, D. &amp; Nesvizhskii, A. I. MSFragger: ultrafast and comprehensive peptide identification in mass spectrometry-based proteomics. Nat. Methods 14, 513–520 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28394336</ArticleId><ArticleId IdType="pmc">5409104</ArticleId><ArticleId IdType="doi">10.1038/nmeth.4256</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731–740 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27348712</ArticleId><ArticleId IdType="doi">10.1038/nmeth.3901</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543–D552 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34723319</ArticleId><ArticleId IdType="doi">10.1093/nar/gkab1038</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>